Biologics do not reduce colectomy in newly diagnosed ulcerative colitis
September's Inflammatory Bowel Disease investigates incidence of and impact of medications on colectomy in newly diagnosed ulcerative colitis in the era of biologics.
fiogf49gjkf04
The cumulative incidence of colectomy and the impact of 5-aminosalicylates, azathioprine, and ant
Our site uses cookies to improve your experience.You can find out more about our use of cookies in our standard cookie policy, including instructions on how to reject and delete cookies if you wish to do so.
By continuing to browse this site you agree to us using cookies as described in our
standard cookie policy .